Abstract
It is an honor—indeed thrilling—to be asked to predict the future of the antiphospholipid syndrome (APS). It would be even more thrilling had not the preceding chapters, and the creation of the consortium that inspired this volume, not done my assignment for me. The pages that precede these, written by some of the best people working in the field, draw roadmap for the next decade that is as good as any I could have drawn on my own. Nevertheless, I will try to respond to the challenge. Twice before, in 2000 and in 2006, I tried to predict the future of APS. First, I wrote that the challenges in 2000 were: to distinguish clinically between APS and the genetic coagulopathies, to understand the relationship between antibody and clinical illness, to learn the molecular features of antigen and antibody that might lead to thrombosis, to develop animal models, and to establish consortia for clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lockshin MD. Prognosis and future directions. In: Hughes GRV, Khamashta MA, editors. Hughes syndrome. London: Springer-Verlag; 2000. p. 459–62.
Lockshin MD. The future of Hughes syndrome. In: Khamashta MA, editor. Hughes syndrome. Antiphospholipid syndrome. London: Springer-Verlag; 2006. p. 579–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lockshin, M.D. (2012). Remembrances of Predictions Past. In: Erkan, D., Pierangeli, S. (eds) Antiphospholipid Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3194-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3194-7_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-3193-0
Online ISBN: 978-1-4614-3194-7
eBook Packages: MedicineMedicine (R0)